Tilray Brands (TLRY) Cash from Investing Activities (2017 - 2026)
Tilray Brands (TLRY) reported Cash from Investing Activities of $28.9 million for Q1 2026, up 24400.0% on a YoY basis from N/an in Q1 2025, and up 149.85% quarter-over-quarter from -$58.0 million in Q4 2025.
Tilray Brands (TLRY) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Tilray Brands has reported Cash from Investing Activities for 10 years, with the latest figure at $28.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 24400.0% year-over-year to $28.9 million; the trailing twelve-month figure through Feb 2026 stood at $8.9 million (up 158.62% YoY), and the FY2025 full-year result was -$46.7 million, down 136.4% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $28.9 million, up from -$58.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $81.5 million in Q4 2023, with the low at -$271.4 million in Q4 2022.
- Historically, Cash from Investing Activities has averaged -$12.6 million across 5 years, with a median of -$1.5 million in 2022.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 3792.69% — and 2026, when it soared 24400.0%.
- Tilray Brands' Cash from Investing Activities stood at -$271.4 million in 2022, then surged by 130.03% to $81.5 million in 2023, then tumbled by 113.16% to -$10.7 million in 2024, then tumbled by 440.84% to -$58.0 million in 2025, then jumped by 149.85% to $28.9 million in 2026.
- The last three Cash from Investing Activities figures came in at $28.9 million (Q1 2026), -$58.0 million (Q4 2025), and $24.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 28.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 28.92 Mn |
| Feb 28, 2026 | 28.92 Mn |
| Nov 30, 2025 | -58.01 Mn |
| Nov 30, 2025 | -58.01 Mn |
| Aug 31, 2025 | 24.47 Mn |
| Aug 31, 2025 | 24.47 Mn |
| May 31, 2025 | 13.52 Mn |
| May 31, 2025 | 13.52 Mn |
| Feb 28, 2025 | -119,000.00 |
| Feb 28, 2025 | -119,000.00 |
| Nov 30, 2024 | -10.73 Mn |
| Nov 30, 2024 | -10.73 Mn |
| Aug 31, 2024 | -49.40 Mn |
| Aug 31, 2024 | -49.40 Mn |
| May 31, 2024 | 45.06 Mn |
| May 31, 2024 | 45.06 Mn |
| Feb 29, 2024 | 28.09 Mn |
| Feb 29, 2024 | 28.09 Mn |
| Nov 30, 2023 | 81.50 Mn |
| Nov 30, 2023 | 81.50 Mn |